Fisherman drowns as boat capsizes near Ullal; two rescued

Udupi, May 2: All the 18 people who were advised self-quarantine in connection with the Thekkatte petrol bunk incident have been tested negative, however, they were asked to continue the 14-day quarantine, said DHO Sudhirchandra Suda on Saturday.

the petrol bunk at Thekkatte was sealed after a Covid infected person had food and took bath at the petrol bunk, while he was travelling from Mumbai to Mandya.

The employees and the owner of the petrol bunk along with the six employees at Sasthana toll gate were asked to quarantine themselves for 14 days.

Udupi, Jul 26: Two persons including a lady doctor have been arrested by the Kaup police in Udupi district for trying to use fake salary documents to avail loan from a bank to buy a car. 

According to police, on July 24, the doctor had visited Bank of Baroda's branch office at Kaup Moodabettu. She had approached the branch manager for a car loan for herself and her brother. She claimed that her monthly salary is Rs 2.66 lakh.

The bank verified the details furnished along with the loan application. The bank found that even though the doctor had furnished salary slips of Manipal Academy of Higher Education, she was presently not employed there.

The bank manager has filed a complaint at Kaup police station, accusing the doctor of trying to cheat the bank by availing loan on the basis of fake documents.

The police registered a case and nabbed her when she visited the Katapady branch of the same bank today. The police also arrested a man, who according to the doctor, created fake documents for her.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.